- Pharmaceutical companies
- Curium
Curium
Phone: +358 14 334 5211
E-mail: orders.finland@curiumpharma.com
Web: https://www.curiumfinland.fi/
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products to customers around the globe. Drawing on years of proven experience, we aim to drive the nuclear medicine industry forward through excellence, reliability and unparalleled service. We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. Curium specialises in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment, and proven patient outcomes.
For detailed contact information visit location pages below.
Curium's locations around the world
Clinical Trials sponsored by Curium
-
Curium US LLCActive, not recruitingMetastasis From Malignant Tumor of ProstateUnited States, France, Spain, Italy
-
Curium US LLCRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
Curium US LLCCompletedProstate Cancer | Prostate Adenocarcinoma | Biochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
Curium US LLCCompletedMetastasis From Malignant Tumor of Prostate (Disorder)United States
-
Curium PET FranceActive, not recruitingProstate Cancer RecurrentFrance
-
Curium US LLCApproved for marketing
-
Weill Medical College of Cornell UniversityCurium US LLCRecruiting
-
Veerle RuijtersZonMw: The Netherlands Organisation for Health Research and Development; Curium...Not yet recruitingGlioblastoma | Radionecrosis of BrainNetherlands